ACME Laboratories (DHA:ACMELAB) Short-Term Capital Lease Obligation : BDT20 Mil (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is ACME Laboratories Short-Term Capital Lease Obligation?

ACME Laboratories's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2024 was BDT20 Mil.

ACME Laboratories's quarterly Short-Term Capital Lease Obligation declined from Jun. 2024 (BDT21 Mil) to Sep. 2024 (BDT19 Mil) but then increased from Sep. 2024 (BDT19 Mil) to Dec. 2024 (BDT20 Mil).

ACME Laboratories's annual Short-Term Capital Lease Obligation declined from Jun. 2022 (BDT22 Mil) to Jun. 2023 (BDT22 Mil) and declined from Jun. 2023 (BDT22 Mil) to Jun. 2024 (BDT21 Mil).

ACME Laboratories Short-Term Capital Lease Obligation Historical Data

The historical data trend for ACME Laboratories's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ACME Laboratories Short-Term Capital Lease Obligation Chart

ACME Laboratories Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

11.64

14.27

22.33

21.86

21.49

ACME Laboratories Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															-	21.36	21.49	19.40	20.23

ACME Laboratories Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

ACME Laboratories Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of ACME Laboratories's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

ACME Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ACME Laboratories Ltd (DHA:ACMELAB) » Definitions » Short-Term Capital Lease Obligation

Traded in Other Exchanges

N/A

Address

1/4, Kallayanpur, Mirpur Road, Court de la ACME, Dhaka, BGD, 1207

Website

https://www.acmeglobal.com

ACME Laboratories Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products in Bangladesh. The Company is engaged in manufacturing, marketing, and distribution of generic pharmaceuticals formulation products which includes human drugs comprising dosages form like a tablet, capsule, dry syrup, cream, ointment, powder, injection, dry powder inhaler, metered dosage inhaler, suppository, eye and nasal drop, liquid, liquid in hard gelatine, Blow Fill Seal (BFS) products, sachet products; veterinary drugs comprising dosages form like bolus, liquid,injection, water-soluble powder, premix and herbal drugs comprising dosages form like liquid, capsule, tablet, cream. The products of the company are sold in domestic and international markets.

ACME Laboratories Headlines

No Headlines